These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 19996135

  • 1. High-dose tranexamic Acid is associated with nonischemic clinical seizures in cardiac surgical patients.
    Murkin JM, Falter F, Granton J, Young B, Burt C, Chu M.
    Anesth Analg; 2010 Feb 01; 110(2):350-3. PubMed ID: 19996135
    [Abstract] [Full Text] [Related]

  • 2. Tranexamic Acid in cardiac surgery and postoperative seizures: a case report series.
    Bell D, Marasco S, Almeida A, Rowland M.
    Heart Surg Forum; 2010 Aug 01; 13(4):E257-9. PubMed ID: 20719731
    [Abstract] [Full Text] [Related]

  • 3. Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.
    Martin K, Knorr J, Breuer T, Gertler R, Macguill M, Lange R, Tassani P, Wiesner G.
    J Cardiothorac Vasc Anesth; 2011 Feb 01; 25(1):20-5. PubMed ID: 21272777
    [Abstract] [Full Text] [Related]

  • 4. High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement.
    Keyl C, Uhl R, Beyersdorf F, Stampf S, Lehane C, Wiesenack C, Trenk D.
    Eur J Cardiothorac Surg; 2011 May 01; 39(5):e114-21. PubMed ID: 21295991
    [Abstract] [Full Text] [Related]

  • 5. Risk factors associated with postoperative seizures in patients undergoing cardiac surgery who received tranexamic acid: a case-control study.
    Montes FR, Pardo DF, Carreño M, Arciniegas C, Dennis RJ, Umaña JP.
    Ann Card Anaesth; 2012 May 01; 15(1):6-12. PubMed ID: 22234015
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K, Wijeysundera DN, Yau TM, McCluskey SA, Tait G, Beattie WS.
    Anesth Analg; 2010 Jan 01; 110(1):21-9. PubMed ID: 19910626
    [Abstract] [Full Text] [Related]

  • 8. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
    Casati V, Guzzon D, Oppizzi M, Bellotti F, Franco A, Gerli C, Cossolini M, Torri G, Calori G, Benussi S, Alfieri O.
    J Thorac Cardiovasc Surg; 2000 Sep 01; 120(3):520-7. PubMed ID: 10962414
    [Abstract] [Full Text] [Related]

  • 9. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.
    Martin K, Wiesner G, Breuer T, Lange R, Tassani P.
    Anesth Analg; 2008 Dec 01; 107(6):1783-90. PubMed ID: 19020118
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tranexamic acid: how much is enough?
    Fox MA.
    Anesth Analg; 2010 Aug 01; 111(2):580-1; author reply 581. PubMed ID: 20664102
    [No Abstract] [Full Text] [Related]

  • 12. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K, Beattie WS, Dattilo KM, McCluskey SA, Ghannam M, Hamdy A, Wijeysundera DN, Fedorko L, Yau TM.
    Transfusion; 2006 Mar 01; 46(3):327-38. PubMed ID: 16533273
    [Abstract] [Full Text] [Related]

  • 13. Low-Dose Versus High-Dose Tranexamic Acid Reduces the Risk of Nonischemic Seizures After Cardiac Surgery With Cardiopulmonary Bypass.
    Couture P, Lebon JS, Laliberté É, Desjardins G, Chamberland MÈ, Ayoub C, Rochon A, Cogan J, Denault A, Deschamps A.
    J Cardiothorac Vasc Anesth; 2017 Oct 01; 31(5):1611-1617. PubMed ID: 28803773
    [Abstract] [Full Text] [Related]

  • 14. Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.
    Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.
    J Cardiothorac Vasc Anesth; 2008 Feb 01; 22(1):6-15. PubMed ID: 18249324
    [Abstract] [Full Text] [Related]

  • 15. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF, Maas JJ, Engbers FH, Versteegh MI, Bruggemans EF, Dion RA, Klautz RJ.
    Eur J Cardiothorac Surg; 2009 Aug 01; 36(2):322-9. PubMed ID: 19250838
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study.
    Elwatidy S, Jamjoom Z, Elgamal E, Zakaria A, Turkistani A, El-Dawlatly A.
    Spine (Phila Pa 1976); 2008 Nov 15; 33(24):2577-80. PubMed ID: 19011538
    [Abstract] [Full Text] [Related]

  • 17. Seizures following cardiac surgery: the impact of tranexamic acid and other risk factors.
    Manji RA, Grocott HP, Leake J, Ariano RE, Manji JS, Menkis AH, Jacobsohn E.
    Can J Anaesth; 2012 Jan 15; 59(1):6-13. PubMed ID: 22065333
    [Abstract] [Full Text] [Related]

  • 18. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T, Martin K, Wilhelm M, Wiesner G, Schreiber C, Hess J, Lange R, Tassani P.
    Eur J Cardiothorac Surg; 2009 Jan 15; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.